b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30565030</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>16</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1573-2576</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>42</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Jun</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Inflammation</Title>\n                <ISOAbbreviation>Inflammation</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Inhibition of Carrageenan/Kaolin-Induced Arthritis in Rats and of Inflammatory Cytokine Expressions in Human IL-1\xce\xb2-Stimulated Fibroblast-like Synoviocytes by a Benzylideneacetophenone Derivative.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>928-936</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10753-018-0947-8</ELocationID>\n            <Abstract>\n                <AbstractText>The benzylideneacetophenone derivative JC3 [(2E)-3-(4-hydroxy-3-methoxyphenyl)phenylpro-2-en-l-one] (JC3) was synthesized by modifying yakuchinone B obtained from the seeds of Alpinia oxyphylla, a member of the ginger family (Zingiberaceae), which are widely used as a folk remedy and as an anti-inflammatory. The aim of this study was to investigate the anti-arthritic effects of JC3 in rat models of carrageenan-induced paw pain and carrageenan/kaolin-induced knee arthritis. The anti-nociceptive effect of JC3 was assessed by measuring paw withdrawal pressure thresholds using an analgesy-meter. Arthritic symptoms in our monoarthritic rat model were evaluated using weight distribution ratios (WDR), paw thicknesses, and serum prostaglandin E2 (PGE2), tumor necrosis factor (TNF)-\xce\xb1, interleukin (IL)-6, and vascular endothelial growth factor (VEGF) levels (determined by ELISA). Histological analyses of knee joints were performed after injecting JC3 intraperitoneally into rats before carrageenan treatment at 5 or 10\xc2\xa0mg/kg/day for 6\xc2\xa0days. The anti-inflammatory effects of JC3 were investigated in vitro using interleukin-1beta (IL-1\xce\xb2)-stimulated fibroblast-like synoviocytes (FLS) derived from arthritis patients. PGE2, IL-6, and IL-8 levels were measured after treating FLS with JC3. In arthritis-induced rats, JC3 treatment significantly decreased nociceptive and arthritic symptoms at days 5 to 6 after carrageenan/kaolin injection. Histological staining of knee tissue showed that JC3 significantly reduced inflammatory areas in the knee joints. Furthermore, JC3 inhibited the expressions of IL-6 and IL-8 in FLS cells at concentrations of 5-10\xc2\xa0\xce\xbcg/ml and decreased PGE<sub>2</sub> levels in FLS cells. These findings suggest JC3 has anti-arthritic effects in in vivo and in vitro, and that it might be useful for the treatment of arthritis.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Sur</LastName>\n                    <ForeName>Bongjun</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Molecular Medicine and TIDRC, School of Medicine, Ewha Womans University, Seoul, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kang</LastName>\n                    <ForeName>Seungmin</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Molecular Medicine and TIDRC, School of Medicine, Ewha Womans University, Seoul, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kim</LastName>\n                    <ForeName>Mijin</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Molecular Medicine and TIDRC, School of Medicine, Ewha Womans University, Seoul, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Oh</LastName>\n                    <ForeName>Seikwan</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Molecular Medicine and TIDRC, School of Medicine, Ewha Womans University, Seoul, Republic of Korea. skoh@ewha.ac.kr.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Inflammation</MedlineTA>\n            <NlmUniqueID>7600105</NlmUniqueID>\n            <ISSNLinking>0360-3997</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C532465">(2E)-3-(4-hydroxy-3-methoxyphenyl) phenylpro-2-1-one</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000700">Analgesics</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D001597">Benzylidene Compounds</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011427">Propiophenones</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>24H4NWX5CO</RegistryNumber>\n                <NameOfSubstance UI="D007616">Kaolin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>9000-07-1</RegistryNumber>\n                <NameOfSubstance UI="D002351">Carrageenan</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000700" MajorTopicYN="N">Analgesics</DescriptorName>\n                <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName>\n                <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001169" MajorTopicYN="N">Arthritis, Experimental</DescriptorName>\n                <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001597" MajorTopicYN="N">Benzylidene Compounds</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002351" MajorTopicYN="N">Carrageenan</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>\n                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007616" MajorTopicYN="N">Kaolin</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011427" MajorTopicYN="N">Propiophenones</DescriptorName>\n                <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000070918" MajorTopicYN="N">Synoviocytes</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Anti-inflammatory</Keyword>\n            <Keyword MajorTopicYN="N">Arthritis</Keyword>\n            <Keyword MajorTopicYN="N">Benzylideneacetophenone derivative</Keyword>\n            <Keyword MajorTopicYN="N">Fibroblast-like synoviocytes</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>20</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>18</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>20</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30565030</ArticleId>\n            <ArticleId IdType="doi">10.1007/s10753-018-0947-8</ArticleId>\n            <ArticleId IdType="pii">10.1007/s10753-018-0947-8</ArticleId>\n            <ArticleId IdType="pmc">PMC6527524</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Mutat Res. 1999 Jul 16;428(1-2):49-57</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10517978</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Altern Med Rev. 1999 Dec;4(6):392-402</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10608912</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharmacol. 2000 Sep 22;404(3):375-85</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10996603</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Rheumatol. 2001;20(3):192-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11434472</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurosci Methods. 2002 Mar 30;115(1):107-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11897370</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Food Chem Toxicol. 2002 Aug;40(8):1091-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12067569</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arthritis Res. 2002;4 Suppl 3:S81-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12110126</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Inflammation. 2004 Feb;28(1):15-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15072226</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Rheumatology (Oxford). 2004 Jun;43 Suppl 3:iii2-iii9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15150426</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Opin Biol Ther. 2004 Jun;4(6):847-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15174967</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Immunol. 2005 May;115(2):118-28</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15885632</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Chem Pharm Bull (Tokyo). 1992 Feb;40(2):387-91</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1606634</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Pharm Res. 2006 Jun;29(6):469-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16833013</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Phytother Res. 2007 Jul;21(7):675-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17444576</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arthritis Res Ther. 2007;9(4):R80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17697361</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Clin Pract Rheumatol. 2007 Nov;3(11):635-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17968334</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Phytother Res. 2008 Oct;22(10):1389-95</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18688813</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Microbiol Biotechnol. 2008 Oct;18(10):1641-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18955812</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arthritis Res Ther. 2009;11(2):R49</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19327174</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arthritis Rheum. 2009 Oct;60(10):3061-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19790055</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antiviral Res. 1990 Feb;13(2):61-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2160796</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Inflamm Res. 2015 Nov;64(11):853-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26261076</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 1986 Feb;77(2):645-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">3003163</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Indian J Exp Biol. 1973 May;11(3):183-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">4782618</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Anaesth. 1995 Aug;75(2):125-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7577246</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Rheumatol. 1997 May;9(3):236-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9204259</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'